Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

By Maggie Fick LONDON (Reuters) -AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe ...

Swiss and French pharmaceutical companies Novartis and Sanofi are pushing for higher medicine prices in Europe. This content ...

FDA Commissioner Marty Makary talks about his plans to revamp drug development and reduce ‘conflicts of interest’ between the ...

Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.

European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels paid by the US, ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

The Cancer Biologics Market is witnessing remarkable growth fueled by an expanding therapeutic landscape and a burgeoning pipeline of innovative biologic therapies. Unlike traditional treatments, ...